[1]
“NOVEL TREATMENT APPROACHES IN REACTIVE ARTHRITIS: CLINICAL AND CYTOKINE RESPONSES TO IGURATIMOD 25 MG COMPARED WITH BIOLOGIC AND CONVENTIONAL THERAPIES”, JUSR, vol. 1, no. Maxsus son (FARMAKOLOGIYA, FARMATSEVTIKA, pp. 86–86, Dec. 2025, doi: 10.66301/jusr.v1i0.14971.